PERRI CLIFFORD: Open Payments
NPI 1285246488 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,645 in 125 payments from 21 companies in 2025. Trend: 2023 $1,949 · 2024 $1,759 · 2025 $1,645
Food & beverage: $1,645
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 36 | $310 |
| Lundbeck LLC | 21 | $228 |
| Neurocrine BioSciences, Inc. | 13 | $171 |
| UCB, Inc. | 8 | $153 |
| ABBVIE INC. | 17 | $148 |
| SK Life Science, Inc. | 11 | $142 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Noctrix Health, Inc. | 1 | $54 |
| ARGENX US, INC. | 2 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $44 |
Products named: NURTEC ODT, INGREZZA, VYEPTI, UBRELVY, REXULTI, Nayzilam, KESIMPTA, NIDRA.
Industry payments across NY — which companies pay providers there.
